Li-Wei Kuo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Li-Wei Kuo has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Jennifer K. Richer
University of Colorado Anschutz Medical Campus 1 Department of Pathology Aurora, Colorado
163 shared publications - Lyndsey S. Crump
University of Colorado Anschutz Medical Campus 1 Department of Pathology Aurora, Colorado
163 shared publications - Kathleen O’nEill
University of Colorado Anschutz Medical Campus 1 Department of Pathology Aurora, Colorado
134 shared publications - Benjamin G. Bitler
Department of OB/GYN, The University of Colorado Anschutz Medical Campus, Aurora, Colorado
131 shared publications - Mike Bickerdike
Antido Therapeutics, Melbourne, Australia. 6
131 shared publications - Andrew Goodspeed
University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado
126 shared publications
Latest Publications
- Open Access
- 26 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (17) , 7643
Correction: Simbulan-Rosenthal et al. Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells. Int. J. Mol. Sci. 2022, 23, 2333
- 26 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (17) , 7643
Open AccessCorrection: Simbulan-Rosenthal et al. Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells. Int. J. Mol. Sci. 2022, 23, 2333
- 21 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 19 (947)
NDRG1 expression in cancers confers dependence on DNA damage repair and sensitivity to quinacrine
Cancer cells exploit DNA repair to overcome damage and errors induced by rapid proliferation and repressed checkpoints. Thus, the loss of one DNA repair protein can make tumors more susceptible to inhibition of other repair pathways. Here, using in silico methodologies and high-content genetic and cell survival screens, we found that the antimalarial drug quinacrine impaired the DNA damage response (DDR) in multiple cancer cell lines. Quinacrine disrupted the interaction of the stress-response protein NDRG1 with the major segregase VCP, which in turn promoted the degradation of the E3 ubiquitin ligase RNF8 and other proteins that mediate the recruitment of the critical DDR protein 53BP1 to sites of DNA damage. This impaired recruitment of 53BP1 caused increases in the DNA damage marker γH2AX. High NDRG1 expression in tumors correlated with poor survival in patients, and high expression in various cancer cell lines correlated with quinacrine sensitivity. Colorectal carcinoma cells were particularly vulnerable to pharmacological or genetic inhibition of NDRG1, and high NDRG1 expression and mutations in MLH1 and PARP3 resulted in synthetic lethality. Our findings identify combination genetic markers that might be therapeutically exploited in colon cancer, as well as provide a platform for such discovery in distinct cancer types.
- 21 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 19 (947)
NDRG1 expression in cancers confers dependence on DNA damage repair and sensitivity to quinacrine
Cancer cells exploit DNA repair to overcome damage and errors induced by rapid proliferation and repressed checkpoints. Thus, the loss of one DNA repair protein can make tumors more susceptible to inhibition of other repair pathways. Here, using in silico methodologies and high-content genetic and cell survival screens, we found that the antimalarial drug quinacrine impaired the DNA damage response (DDR) in multiple cancer cell lines. Quinacrine disrupted the interaction of the stress-response protein NDRG1 with the major segregase VCP, which in turn promoted the degradation of the E3 ubiquitin ligase RNF8 and other proteins that mediate the recruitment of the critical DDR protein 53BP1 to sites of DNA damage. This impaired recruitment of 53BP1 caused increases in the DNA damage marker γH2AX. High NDRG1 expression in tumors correlated with poor survival in patients, and high expression in various cancer cell lines correlated with quinacrine sensitivity. Colorectal carcinoma cells were particularly vulnerable to pharmacological or genetic inhibition of NDRG1, and high NDRG1 expression and mutations in MLH1 and PARP3 resulted in synthetic lethality. Our findings identify combination genetic markers that might be therapeutically exploited in colon cancer, as well as provide a platform for such discovery in distinct cancer types.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 10 from Metastasis-Associated Wound Repair Promotes Reciprocal Lung Epithelium Activation and Breast Cancer Metastatic Outgrowth
IAT2 cells co-cultured with TNBC cells.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 10 from Metastasis-Associated Wound Repair Promotes Reciprocal Lung Epithelium Activation and Breast Cancer Metastatic Outgrowth
IAT2 cells co-cultured with TNBC cells.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure 2 from Metastasis-Associated Wound Repair Promotes Reciprocal Lung Epithelium Activation and Breast Cancer Metastatic Outgrowth
Chronic wound repair in the lung surrounding growing metastases. A, MMTV-PyMT metastatic lungs were H&E- and IHC-stained for cell-specific markers of lung wound repair (n > 50 metastases from 2–7 mice per stain; see Supplementary Table S1A for sample number details). Shown are representative images from metastases of different sizes, with black arrows indicating small metastases; scale bar, 100 μm. The percentage of positively stained cells, normalized to the total number of cells, was quantified in the 100 μm surrounding metastases. Mean ± SEM (unpaired t tests with Welch correction); *, P ≤ 0.05; ***, P < 0.001. B, Multi-IF staining for a lung wound repair cell signature in MMTV-PyMT and Met-1 metastatic lungs. Shown are representative images from MMTV-PyMT metastases of different sizes; scale bars, 25 μm, inset zoom 3×. The wound repair score, calculated as the total number of wound repair–related cells in the 300 μm surrounding metastases from the spontaneous MMTV-PyMT metastasis model (n = 16 metastases from 2–4 mice; unpaired t tests with Welch correction) and the late-stage Met-1 intravenous (IV) metastasis model (n = 50 metastases from five mice; unpaired t tests). Mean ± SEM. C, MMTV-PyMT metastatic lungs were stained for cell-specific activation markers. Shown are representative images from metastases of different sizes, with black arrows indicating small metastases. For polarized light picrosirius red images, metastases are outlined in white. BV, blood vessel; scale bar, 100 μm, inset zoom 4×. D, Multi-IF staining of MMTV-PyMT metastatic lungs for AT2 cell activation. Shown are representative images from metastases of different sizes, with white arrows indicating proSP-C and Ki67 double-positive proliferating AT2 cells; scale bars, 25 μm, inset zoom 3×. The percentage of proSP-C–positive cells that are Ki67-positive was quantified in the lung surrounding metastases: 300 μm for nonadjacent cells (n = 17 metastases from 3–5 mice; unpaired t tests); mean ± SEM. E, Cytokine array performed on lungs from mice with a low or high metastatic burden using the late-stage Met-1 IV metastasis model (n = 3 mice per group; multiple unpaired t tests with Welch correction). Mean ± SEM; *, P ≤ 0.05. S, small; M, medium; L, large metastases.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 2 from Metastasis-Associated Wound Repair Promotes Reciprocal Lung Epithelium Activation and Breast Cancer Metastatic Outgrowth
Chronic wound repair in the lung surrounding growing metastases. A, MMTV-PyMT metastatic lungs were H&E- and IHC-stained for cell-specific markers of lung wound repair (n > 50 metastases from 2–7 mice per stain; see Supplementary Table S1A for sample number details). Shown are representative images from metastases of different sizes, with black arrows indicating small metastases; scale bar, 100 μm. The percentage of positively stained cells, normalized to the total number of cells, was quantified in the 100 μm surrounding metastases. Mean ± SEM (unpaired t tests with Welch correction); *, P ≤ 0.05; ***, P < 0.001. B, Multi-IF staining for a lung wound repair cell signature in MMTV-PyMT and Met-1 metastatic lungs. Shown are representative images from MMTV-PyMT metastases of different sizes; scale bars, 25 μm, inset zoom 3×. The wound repair score, calculated as the total number of wound repair–related cells in the 300 μm surrounding metastases from the spontaneous MMTV-PyMT metastasis model (n = 16 metastases from 2–4 mice; unpaired t tests with Welch correction) and the late-stage Met-1 intravenous (IV) metastasis model (n = 50 metastases from five mice; unpaired t tests). Mean ± SEM. C, MMTV-PyMT metastatic lungs were stained for cell-specific activation markers. Shown are representative images from metastases of different sizes, with black arrows indicating small metastases. For polarized light picrosirius red images, metastases are outlined in white. BV, blood vessel; scale bar, 100 μm, inset zoom 4×. D, Multi-IF staining of MMTV-PyMT metastatic lungs for AT2 cell activation. Shown are representative images from metastases of different sizes, with white arrows indicating proSP-C and Ki67 double-positive proliferating AT2 cells; scale bars, 25 μm, inset zoom 3×. The percentage of proSP-C–positive cells that are Ki67-positive was quantified in the lung surrounding metastases: 300 μm for nonadjacent cells (n = 17 metastases from 3–5 mice; unpaired t tests); mean ± SEM. E, Cytokine array performed on lungs from mice with a low or high metastatic burden using the late-stage Met-1 IV metastasis model (n = 3 mice per group; multiple unpaired t tests with Welch correction). Mean ± SEM; *, P ≤ 0.05. S, small; M, medium; L, large metastases.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from Metastasis-Associated Wound Repair Promotes Reciprocal Lung Epithelium Activation and Breast Cancer Metastatic Outgrowth
Lung scRNAseq cell clusters: Low vs High.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from Metastasis-Associated Wound Repair Promotes Reciprocal Lung Epithelium Activation and Breast Cancer Metastatic Outgrowth
Lung scRNAseq cell clusters: Low vs High.